"Revival of Older Weight Loss Drugs: Zepbound and Wegovy Inaccessible to Majority"
Older weight loss drugs are making a comeback as newer medications like Zepbound and Wegovy remain out of reach for many patients due to insurance hurdles and shortages. Patients are turning to older prescription medicines like Ozempic and Saxenda, which are more affordable and come with different side effects. The prescription rates for these older drugs, such as bupropion and phentermine, have increased significantly in recent years. However, the popularity of new drugs has led to a boom in weight-loss prescriptions overall. Doctors are reaching for these older medicines as alternatives, but they must balance the benefits with potential risks, such as muscle loss and malnutrition. Patients are hopeful for better access to newer drugs like Zepbound, but insurance coverage remains a challenge.
